Carolina Blood and Cancer Care | Association Partnerships

Latest from Carolina Blood and Cancer Care


Differentiating Pseudoprogression From Hyperprogression in Patients Treated With Immunotherapies

February 14, 2022

Advances in the field have also led to the recognition of other clinical challenges, including unforeseen observations and complications associated with choosing the sequencing of appropriate therapeutic interventions as well as the management of drug-related complications.